Evidence map›Paper›PMID 37069357›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2023

Transdiagnostic evaluation of epigenetic age acceleration and burden of psychiatric disorders.

Natan Yusupov, Linda Dieckmann, Mira Erhart, Susann Sauer, Monika Rex-Haffner, Johannes Kopf-Beck, Tanja M Brückl, Darina Czamara, Elisabeth B Binder

Open access · hybridAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Natan YusupovDepartment of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, 80804, Germany. natan_yusupov@psych.mpg.de.
Linda DieckmannDepartment of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, 80804, Germany.
Mira ErhartDepartment of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, 80804, Germany.
Susann SauerDepartment of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, 80804, Germany.
Monika Rex-HaffnerDepartment of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, 80804, Germany.
Johannes Kopf-BeckDepartment of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, 80804, Germany.
Tanja M BrücklDepartment of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, 80804, Germany.
Darina CzamaraDepartment of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, 80804, Germany.ORCID 0000-0001-7381-904X
Elisabeth B BinderDepartment of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, 80804, Germany.ORCID 0000-0001-7088-6618
Max Planck Institute of Psychiatry · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Different psychiatric disorders as well as exposure to adverse life events have individually been associated with multiple age-related diseases and mortality. Age acceleration in different epigenetic clocks can serve as biomarker for such risk and could help to disentangle the interplay of psychiatric comorbidity and early adversity on age-related diseases and mortality. We evaluated five epigenetic clocks (Horvath, Hannum, PhenoAge, GrimAge and DunedinPoAm) in a transdiagnostic psychiatric sample using epigenome-wide DNA methylation data from peripheral blood of 429 subjects from two studies at the Max Planck Institute of Psychiatry. Burden of psychiatric disease, represented by a weighted score, was significantly associated with biological age acceleration as measured by GrimAge and DunedinPoAm (R2-adj. 0.22 and 0.33 for GrimAge and DunedinPoAm, respectively), but not the other investigated clocks. The relation of burden of psychiatric disease appeared independent of differences in socioeconomic status and medication. Our findings indicate that increased burden of psychiatric disease may associate with accelerated biological aging. This highlights the importance of medical management of patients with multiple psychiatric comorbidities and the potential usefulness of specific epigenetic clocks for early detection of risk and targeted intervention to reduce mortality in psychiatric patients.

Indexed as

AccelerationMental DisordersAgingDNA MethylationEpigenesis, GeneticHumans

Identifiers

PMID37069357
PMCPMC10354057
OpenAlexW4366087947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.